Norbrook has announced the winner of this year’s Closamectin Combi Clamp competition – an initiative that captured the interest of farmers at livestock shows across the UK earlier this year.
Norbrook® Laboratories Ltd was founded by the late Lord Ballyedmond, in 1969, when he pioneered contract manufacturing of pharmaceuticals in the UK. Since then Norbrook has grown to be a worldwide leader in veterinary finished dose form products, medical finished dose form products and bulk pharmaceutical synthesis, making them a leader in the world in the production of pharmaceutical raw materials.
History of Norbrook
|1969||Norbrook was founded.|
|1970||Norbrook began manufacture of veterinary pharmaceuticals|
|1974||The first Norbrook patent was granted|
|1978||Norbrook expanded into Africa|
|1980||Norbrook expanded into Japan|
|1987||Norbrook received its first Queens Award for Export|
|1990||Norbrook expanded into Eastern Europe|
|1994||Norbrook announced its £38m expansion programme|
|1996||Norbrook expanded into People’s Republic of China|
|1998||Norbrook expanded into medical and raw material pharmaceutical production|
|2000||Norbrook expanded into Australia and New Zealand|
|2001||Norbrook launched their first major product for cats and dogs globally|
|2002||Norbrook received the Queens Award for Export Achievement for the fourth time|
|2006||Norbrook’s novel combination of Ivermectin and Closantel received its license by the UK regulatory authorities.
Norbrook invested £30m in a molecular development facility
|2009||Norbrook launched Closamectin Pour On for cattle|
|2010||Norbrook launched Closamectin Injection for sheep|
Norbrook received the Queens Award for Enterprise